← All candidates
Four insider buys in the last year — $3.27M in all.
Rick W. AllenEducation and Workforce · Energy and Commercetraded 14 Jul · filed 18 Aug · spouseSold$15K–$50Kspouse14 Jul64d ago18 Aug29d ago
Richard McCormickScience, Space, and Technology · Armed Services +1traded 30 Jul · filed 14 Aug · selfSold$1K–$15Kself30 Jul48d ago14 Aug33d ago
52 filings on record.
ABTABBOTT LABORATORIES
NYSE · Healthcare · $178.41B
$102.03
+0.32% today
Four insider buys in the last year — $3.27M in all.
Nothing in the last fortnight.
Price · 1Y · daily● 4 buys● 11 sells◆ 5 8-K
▸ hover a marker for the filing · drag to zoom · daily bars sharpen to 30-min on close ranges · 2 moves explained
AI brief · from the filings on this pagePro
The filings, the score and the setup on this page, read for you in about ten seconds — what the insiders did, and what stands against it.
Market cap
$178.41B
Float
1719.9M
99% public
Short % float
Pro
Price / profit
33.4
Price / future profit
17.0
Price / sales
3.8
The buyers
▸ each insider's past open-market buys, measured ~6 months (120 trading days) later, against the S&P over the same spans · split-adjusted · pre-scheduled 10b5-1 plan trades excluded · past outcomes, not predictions
CHAIRMAN AND CEO
Ford Robert B
Bought $2.01M on Jan 23 — 18,800 sh @ $107.13, held indirect, 8.7% of their stake.
0 of 1 position beat the S&P
Director
Starks Daniel J
Bought $545.2K on Feb 4 — 5,033 sh @ $108.33, held direct, 0.1% of their stake.
0 of 1 position beat the S&P
Director
Stratton John G
Bought $173.6K on May 7 — 2,000 sh @ $86.82, held direct, 8.6% of their stake.
No completed positions to measure
Congress
▸ Disclosures lag trades by 30–45 days.
26 disclosures12 mo
MemberTradeAmountOwnerTradedFiled
The record
newest first
DateTypeInsiderOf stakeShares @ priceValue
43 more transactions on Pro →Context
Wall St
$118.64 avg target
+16.3% vs today · 25 analysts · consensus Buy
▸ relayed analyst opinion, which tends to run optimistic — not our forecast or advice
Earnings · EPS vs forecast
4 of 4 quarters beat
Q1 '26$1.15 act+$0.00
Q4 '25$1.50 act+$0.01
Q3 '25$1.30 act+$0.00
Q2 '25$1.26 act+$0.00
Coverage
Should You Buy Abbott Labs Stock Hand Over Fist Before July 16?Motley Fool · 06-20Citi Believes Abbott (ABT) Shares are Undervalued Relative to Business SegmentsInsider Monkey · 06-19Abbott's CGM Growth Story Stays Intact Despite Q1 ModerationZacks · 06-16How Investors May Respond To Abbott (ABT) Dividend And CE Mark For Dual Glucose‑Ketone SensorSimply Wall St. · 06-14
The file stays open
52 filings on record.
The next one will be too.
▸ SEC EDGAR · FINRA · Nasdaq — public sources only · research, not advice
